Concepedia

Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology

Abdurrahman Işıkdoğan, Doğan Koca, Mehmet Küçüköner, Özge Gümüşay, Adem Dayan, Lütfiye Demir, Çağlayan Geredeli, Murat Koçer, Ülkü Yalçıntaş Arslan, Ali̇ İnal,

Breast Cancer · 2013 · 38 citations · 20 references

DOI

Concepts

References

20

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/<i>neu</i>Oncogene

Dennis J. Slamon, Gary M. Clark, Steven Wong et al. · Science · 1987 · 11.7K citations

, , +14

Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2

Dennis J. Slamon, Brian Leyland‐Jones, Steven Shak et al. · New England Journal of Medicine · 2001 · 11.5K citations · Full text

, , +10

Multicenter Phase II Study of Lapatinib in Patients with Brain Metastases from HER2-Positive Breast Cancer

Nancy U. Lin, Véronique Dièras, Devchand Paul et al. · Clinical Cancer Research · 2009 · 663 citations · Full text

, , +15

HER2 Amplification Ratios by Fluorescence In Situ Hybridization and Correlation with Immunohistochemistry in a Cohort of 6556 Breast Cancer Tissues

Marilyn A. Owens, Bruce Horten, Moacyr M. Da Silva · Clinical Breast Cancer · 2004 · 653 citations

, , +14

Congestive Heart Failure in Older Women Treated With Adjuvant Anthracycline Chemotherapy for Breast Cancer

Mary Pinder, Zhigang Duan, James S. Goodwin et al. · Journal of Clinical Oncology · 2007 · 630 citations · Full text

, , +17